Kristen Coppock, MA, Editor

Sixteen new investigator award (NIA) winners are receiving up to $10,000 in grants from the American Association of Colleges of Pharmacy.

In an appeal to all Americans, Deborah Birx, MD, said everyone has a role in stopping COVID-19 from spreading.

The new guidance for industry (GFI) document, “Policy for Temporary Compounding of Certain Alcohol-Based Hand Sanitizer Products,” was released Saturday.

Thermo Fisher Scientific’s test is designed to provide patient results within 4 hours of a sample being received by a lab.

President Donald Trump announced the “national emergency” designation in a news conference Friday.

The National Community Pharmacists Association, the Arkansas Pharmacists Association, the American Pharmacists Association, and the National Alliance of State Pharmacy Associations took the joint action of filing an amicus brief in the Supreme Court case [Arkansas Attorney General Leslie] Rutledge v. the Pharmaceutical Care Management Association, scheduled to be heard in Washington, DC on April 27, 2020.

Treatment with this peanut immunotherapy consists of 3 phases: Initial Dose Escalation, Up-Dosing, and Maintenance.

Officials with the FDA have approved pembrolizumab (Keytruda, Merck) for the treatment of certain patients with Bacillus Calmette-Guerin-unresponsive, high-risk, non-muscle invasive bladder cancer.

Metformin hydrochloride extended-release tablets are indicated to for improving glycemic control in patients with type 2 diabetes mellitus, as an adjunct to diet and exercise.

Johnson & Johnson and its Janssen Pharmaceutical Cos unit have agreed to a more than $10 million settlement, rather than allowing the matter go to federal trial.

The postponement of USP chapters , , and was applauded by the International Academy of Compounding Pharmacists.

A recent clinical study demonstrated positive long-term benefits of the early intervention combination treatment of metformin plus vildagliptin (Galvus, Norvartis), a dipeptidyl peptidase-4 [DPP-4] inhibitor, for type 2 diabetes (T2D).

The parties included in this agreement in principle represent some of the more than 2,600 lawsuits filed against Purdue Pharma concerning opioids, including the company’s OxyContin products.

There are currently no FDA-approved targeted therapies to treat metastatic MET exon14 skipping-mutated non-small cell lung cancer (NSCLC), according to the Novartis.

Published in Clinical Rehabilitation, investigators found that breathing techniques commonly utilized in yoga may be an effective adjunct intervention for individuals with COPD.

Johnson & Johnson has vowed to appeal Monday’s decision by Judge Thad Balkman.

Announced by the HHS and FDA, the plan seeks to safely import medications that would provide a cost savings to consumers, but some pharmacy and other health care professionals have expressed concerns.

Officials with the FDA have taken action on LEO Pharma’s calcipotriene and betamethasone dipropionate foam and topical suspension products for the topical treatment of plaque psoriasis in patients age 12 years and older.

Data from a pair of phase 3 trials were recently presented at the 10th International AIDS Society Conference on HIV Science (IAS 2019) in Mexico City.

Washington State University College of Pharmacy and Pharmaceutical Studies is teaching students to recognize patients who need intervention to help save lives.

Merck’s antibacterial drug injection—a combination of imipenem, cilastatin and relebactam (Recarbrio) —is indicated for adults with complicated urinary tract infections (cUTI) and complicated intra-abdominal infections (cIAI).

In a prepared statement, Pharmacy Quality Alliance (PQA) Chief Executive Officer Laura Cranston, RPh, said the organization applauds the initiatives outlined in “Executive Order on Improving Price and Quality Transparency in American Healthcare to Put Patients First.”

The approved product is therapeutically equivalent to Genentech’s Tamiflu I Capsules, 30 mg, 45 mg, and 75 mg.

Based on this analysis, a standardized TOC pharmacy education program for COPD was implemented at Rhode Island Hospital in late 2018.

FDA officials have approved Mayne Pharma’s calcipotriene (Sorilux) foam, 0.005% for adolescent patients, according to the company.1

Pharmacists are part of collaborative care models for opioid use disorder (OUD) treatment and suicide prevention.

At the ASHP Summer Meeting in Boston, Michael Botticelli, of the Grayken Center for Addiction at Boston Medical Center, looked at factors that helped create this crisis.

Hospital pharmacists are encouraged to play a larger role for improving patient outcomes.

Overall, 85% of those surveyed were concerned about this problem in the United States, while 20% think that there is a problem in their own workplaces.